Schisandrin B preparation

Details Schisandrin B preparation Schisandrin B preparation

2008-07-08

2008-07-08

Hoffman, Susan Coe (Department: 1655)

Drug, bio-affecting and body treating compositions

Plant material or plant extract of undetermined constitution...

Reexamination Certificate

active

07396544

ABSTRACT:
The present invention provides a composition (e.g., a pharmaceutical composition) for reducing aging-related mitochondrial antioxidant status changes in a subject, wherein the composition comprises Schisandrin B. The present invention further provides a composition (e.g., a pharmaceutical composition) for reducing ischemia-reperfusion injury in an aging subject, wherein the composition comprises Schisandrin B. Also provided are methods for reducing aging-related mitochondrial antioxidant status changes and/or for reducing ischemia-reperfusion injury in an aging subject using the same.

REFERENCES:
patent: 4684628 (1987-08-01), Liu
patent: 5484595 (1996-01-01), Ikeya et al.
patent: 6242012 (2001-06-01), Newmark et al.
patent: 6261565 (2001-07-01), Empie et al.
patent: 6596321 (2003-07-01), Yan et al.
patent: 6605305 (2003-08-01), Zhao
patent: 2002/0127189 (2002-09-01), Myers et al.
patent: 2003/0008048 (2003-01-01), Winston et al.
patent: 2005/0119337 (2005-06-01), Hu et al.
patent: 1415318 (2003-05-01), None
patent: 2186572 (1987-08-01), None
patent: WO00/74697 (2000-12-01), None
Junqueira et al. (Molecular Aspects of Medicine (2004), vol. 25, pp. 5-16).
Ko et al. (Molecular and Cellular Biochemistry (2002), vol. 238, pp. 181-186).
Pan et al. (Planta Medica (2002), vol. 68, pp. 217-220).
Chiu, Poyee et al., “Role of Cytochrome P-450 in Schisandrin B-Induced Antioxidant and Heat Shock Responses in Mouse Liver.” Life Sciences 2005, 77:2887-2895.
Ip, Siupo et al., “Methylenedioxy Group as Determinant of Schisandrin in Enhancing Hepatic Mitochondrial Glutathione in Carbon Tetrachloride-Intoxicated Mice.” Biochemical Pharmacology 1997, 54: 317-9.
Ko, Kamming et al., “Protection against Carbon Tetrachloride Liver Toxicity by Enantiomers of Schisandrin B Associate”. Pharmaceutical Biology 2002, 40 (4): 298-301.
Ko, Kamming et al., “Shengmai San: Traditional Herbal Medicines for Modern Times”. vol. 1, 2002.
Ko, Kamming et al., “Schisandrin B and other Diebnzocyclooctadiene Lignans” In: Herbal and Traditional Medicine: Molecular Aspects of Health. Packer L, Halliwell B, Ong CN, editors. Marcel Dekker: New York, Basel, Hong Kong, 2004, pp. 289-314.
Ji, Yuxia et al., “Preparation and quality evaluation ofSchisandra chinensisparenteral emulsion” Zhongguo Yiyuan Yaoxue Zazhi, 2004, 24(11): 713-714, China.
Du, Yingfeng et al. “Determination of deoxyschizandrin and schizandrin B inSchisandra chinensisand Weiganfutai tablets by RP-HPLC”, Zhongcaoyao, 2004, 35 (5): 519-521, China.
He, Yanping et al. “Quantitative analysis of γ-schizandrin in Manganbao granules, A complex prescription of Chinese medicine”. Zhongguo Zhongyao Zazhi, 1995, 20(9): 541-2, China.
Cui, Langui et al., “Determination of deoxyschizandrin and schisandrin B in Gengnianan tablets by HPLC”, Zhongcaoyao, 2001, 32(5): 409-411, China.
Zhong, Zhaoqing et al. “HPLC determination of schizandrin B in Livoprotect tablets.”. Zhongcaoyao, 1996, 27(4):215-216, China.
Lui, Fengqun et al. “Simultaneous determination of schizandrin A and B in Gandeining pill by HPLC”, Zhongguo Zhongyao Zazhi, 2000, 25(3): 157-158, China.
Tian, Gengcun et al. “The preparation, pharmacology and clinical application of Shengmaisan” Chinese Traditional Patent Medicine, 2000; 22(2): 162-165.
Ko, Kamming et al., “Protective Effect of a Lignan-enriched Extract ofFructus schisandraeon Physical Exercise Induced Muscle Damage in Rat”, Phytotherapy Research, 1996; 10:450-452.
Panossian et al., “Effects of heavy physical exercise and adaptogens on nitric oxide content in human saliva”, Phytomedicine, 1999, 6 (1): 17-26.
Chiu, Poyee et al., “Chronic schisandrin B treatment improves mitochondrial antioxidant status and tissue heat shock protein production in various tissues of young adult and middle-aged rats”, Biogerontology, 2006, 7:199-210.
Chiu, Poyee et al., “(−) Schisandrin B is more potent than its enantiomer in enhancing cellular glutathione and heat shock protein production as well as protecting against oxidant injury in H9c2 cardiomyocytes” Molecular and Cellular Biochemistry, 2006, 289:185-191.
Chiu, Poyee et al., “Effects of Schisandrin B Enantiomers on Cellcular Glutathione and Menadione Toxicity in AML12 Hepatocytes”, Pharmacology, 2006, 77:63-70.

Affiliated with

Also associated with

Rating

Schisandrin B preparation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Schisandrin B preparation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Schisandrin B preparation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2784391